Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies
- PMID: 11763340
Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies
Abstract
Individuals who are deficient in humoral immunity are particularly at risk from infection with enteroviruses, and poliovirus in particular, where antibodies are the main source of protection from disease. Long-term excretion of vaccine strains of poliovirus has been documented for many years and instances of paralytic poliomyelitis in hypogammaglobulinaemic patients who were subsequently found to have been excreting virus for prolonged periods have been reported in the U.S.A., Germany and Japan. The identification of a healthy immunodeficient patient in the U.K. who has probably been excreting type 2 poliovirus for 15 years will be described, with the characteristics of the virus and the results of attempts at treatment so far. Such individuals pose a significant risk to the eradication programme unless they can be identified and treated.
Similar articles
-
Search for poliovirus long-term excretors among patients affected by agammaglobulinemia.Clin Immunol. 2004 Apr;111(1):98-102. doi: 10.1016/j.clim.2003.11.011. Clin Immunol. 2004. PMID: 15093557
-
Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.Diagn Microbiol Infect Dis. 2006 Jan;54(1):23-30. doi: 10.1016/j.diagmicrobio.2005.08.011. Epub 2005 Nov 14. Diagn Microbiol Infect Dis. 2006. PMID: 16290028
-
Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.Emerg Infect Dis. 2016 Oct;22(10):1712-9. doi: 10.3201/eid2210.151071. Emerg Infect Dis. 2016. PMID: 27648512 Free PMC article.
-
Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.Vaccine. 2009 May 5;27(20):2649-52. doi: 10.1016/j.vaccine.2009.02.071. Epub 2009 Mar 3. Vaccine. 2009. PMID: 19428874 Review.
-
[Review of the studies on primary immunodeficiency disorder and vaccine-derived poliovirus].Zhongguo Yi Miao He Mian Yi. 2010 Jun;16(3):279-82, 292. Zhongguo Yi Miao He Mian Yi. 2010. PMID: 20726276 Review. Chinese.
Cited by
-
A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses.J Clin Virol. 2015 Apr;65:32-7. doi: 10.1016/j.jcv.2015.01.023. Epub 2015 Feb 3. J Clin Virol. 2015. PMID: 25766984 Free PMC article.
-
Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.J Virol. 2011 May;85(9):4354-62. doi: 10.1128/JVI.02553-10. Epub 2011 Feb 23. J Virol. 2011. PMID: 21345966 Free PMC article.
-
Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature.J Clin Immunol. 2018 Jul;38(5):610-616. doi: 10.1007/s10875-018-0521-z. Epub 2018 Jun 14. J Clin Immunol. 2018. PMID: 29948575 Review.
-
Long-term excretion of vaccine-derived poliovirus by a healthy child.J Virol. 2004 Dec;78(24):13839-47. doi: 10.1128/JVI.78.24.13839-13847.2004. J Virol. 2004. PMID: 15564492 Free PMC article.
-
Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine.J Virol. 2005 Jan;79(2):1062-70. doi: 10.1128/JVI.79.2.1062-1070.2005. J Virol. 2005. PMID: 15613335 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical